Matti Haavisto
Overview
Explore the profile of Matti Haavisto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ballo H, Tarkia M, Haavisto M, Stark C, Strandberg M, Vahasilta T, et al.
Ultrasound Med Biol
. 2018 Nov;
45(2):568-578.
PMID: 30467033
We evaluated the relationships between regional myocardial strain measured by speckle tracking echocardiography and viability, fibrosis, hypertrophy and oxygen consumption in the infarcted or remote myocardium in a pig model...
2.
Ballo H, Tarkia M, Haavisto M, Stark C, Strandberg M, Vahasilta T, et al.
Cardiovasc Ultrasound
. 2017 Jan;
15(1):1.
PMID: 28069008
Background: We evaluated echocardiographic area-length methods to measure left ventricle (LV) volumes and ejection fraction (EF) in parasternal short axis views in comparison with cardiac computed tomography (CT) in pigs...
3.
Haavisto M, Saraste A, Pirila L, Hannukainen J, Kalliokoski K, Kirjavainen A, et al.
Rheumatology (Oxford)
. 2016 Jun;
55(10):1777-85.
PMID: 27330160
Objective: Increased atherosclerosis in RA is not fully explained by the ordinary risk factors, but it may be related to vascular inflammation. The aim of this study was to investigate...
4.
Tarkia M, Stark C, Haavisto M, Kentala R, Vahasilta T, Savunen T, et al.
Heart
. 2016 Jan;
102(6):465-71.
PMID: 26762238
Background: Levosimendan is an inotropic agent with cardioprotective and vasodilating properties used for the management of acutely decompensated heart failure. We studied the effects of levosimendan treatment on the size...
5.
Tarkia M, Stark C, Haavisto M, Kentala R, Vahasilta T, Savunen T, et al.
J Nucl Cardiol
. 2015 Feb;
22(4):655-65.
PMID: 25698475
Aims: Large animal models are needed to study disease mechanisms in heart failure (HF). In the present study we characterized the functional, metabolic, and structural changes of myocardium in a...